Home › NDC Lookup › RxCUI directory › RxCUI 2572105

Avacopan 10 MG Oral Capsule — RxCUI 2572105

RxNorm drug concept · Semantic clinical drug
RxCUI 2572105 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2572105
Official nameAvacopan 10 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,629 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Avacopan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tavneos is used to treat a serious autoimmune disease called ANCA-associated vasculitis — specifically the types known as GPA and MPA — where your immune system attacks your own bl...
  • What exactly is Tavneos used for, and why do I still need to take steroids?
  • Yes, it genuinely matters. Taking Tavneos with food — especially a full meal — significantly increases how much of the medicine your body actually absorbs. If you take it on an emp...
  • Do I need to take Tavneos with food? Does it matter if I don't?
📖 Read our full Avacopan guide →

🕸️ Concept Web — How Avacopan 10 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Avacopan 10 MG Oral Capsule RxCUI 2572105

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Avacopan 2572100
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tavneos 2572106
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Avacopan Oral Capsule 2572104
    • Avacopan Oral Product 2572102
    • Avacopan Pill 2572103
    • Avacopan Oral Capsule [Tavneos] 2572110
    • Tavneos Oral Product 2572108
    • Tavneos Pill 2572109
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Avacopan 10 MG SCDC · 2572101
  • Avacopan Oral Capsule SCDF · 2572104
  • Avacopan Oral Product SCDG · 2572102
  • Avacopan Pill SCDG · 2572103

Brand-Name Concepts

  • Avacopan 10 MG Oral Capsule [Tavneos] SBD · 2572111
  • Avacopan 10 MG [Tavneos] SBDC · 2572107
  • Avacopan Oral Capsule [Tavneos] SBDF · 2572110
  • Tavneos Oral Product SBDG · 2572108
  • Tavneos Pill SBDG · 2572109
  • Tavneos BN · 2572106

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 2572105 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
73556-0168-01 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-01) / 180 CAPSULE... TAVNEOS ChemoCentryx, Inc. 2021-10-18
73556-0168-02 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-02) / 30 CAPSULE i... TAVNEOS ChemoCentryx, Inc. 2021-10-18
73556-0168-96 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-96) / 30 CAPSULE i... TAVNEOS ChemoCentryx, Inc. 2021-10-18
Observed labelers: ChemoCentryx, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.